Expression and in vitro evaluation of rhesus macaque wild type (wt) and modified CC chemokines

Journal of Medical Primatology

Volumn 27, Issue 2-3, 1998, Pages 113-120

  Bostik, Pavel ^a,c   Villinger, Francois ^a   Brice, Gary T ^a   Chikkala, Nathaniel F ^a   Brar, Sukhdev S ^a   Cruikshank, William W ^b   Adams, Jonathan W ^a   Hillyer, Christopher D ^a   Ansari, Aftab A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Cytokines; Infection; Inhibition; SIV

Indexed keywords

MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

BETA CHEMOKINE; CALCIUM; MACROPHAGE INFLAMMATORY PROTEIN 1; RANTES; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYMPHOCYTE; MACACA; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; VIROLOGY;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CELLS, CULTURED; CHEMOKINES, CC; CHEMOTAXIS, LEUKOCYTE; CLONING, MOLECULAR; HUMANS; LYMPHOCYTES; MACACA MULATTA; MACROPHAGE INFLAMMATORY PROTEIN-1; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RANTES; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0032036648     PISSN: 00472565     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0684.1998.tb00235.x     Document Type: Article

References (38)

1. ALKHATIB G, COMBADIERE C, BRODER CC, FENG Y, KENNEDY PE, MURPHY PM, BERGER EA: CC CKR5: A RANTES, MTP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958, 1996.
2. ALKHATIB G, LIAO F, BERGER EA, FARBER JM: A new SIV co-receptor, STRL-33. Nature 388:238, 1997.
3. ARENZANA-SEISDEDOS F, VIRELIZIER JL, ROUSSET D, CLARK-LEWIS I, LOETSCHER P, MOSER B, BAGGIOLINI M: HIV blocked by chemokine antagonist. Nature 383:400, 1996.
4. BADOLATO R, JOHNSTON JA, WANG JM, MCVICAR D, XU LL, OPPENHEIM JJ, KELVIN DJ: Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J Immunol 155:4004-4010, 1995.
5. BLELL CC, FARZAN M, CHOE H, PAROLIN C, CLARK-LEWIS I, SODROSKI J, SPRINGER TA: The lymhocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829-832, 1996.
6. CHEN Z, ZHOU P, HO DD, LANDAU NR, MARX PA: Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol 71: 2705-2714, 1997.
7. CHOE H, FARZAN M, SUN Y, SULLIVAN N, ROLLENS B, PONATH PD, WU L, MACKAY CR, LAROSA G, NEWMAN W, GERARD N, GERARD C, SODROSKI J: The β-Chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148, 1996.
8. + T cells. Science 270:1811-1815, 1995.
9. DEAN M, CARRINGTON M, WINKLER C, HUTTLEY GA, SMITH MW, ALLIKMETS R, GOEDERT JJ, BUCHBINDER SP, VITTLNG- HOFF E, GOMPERTS E, DONFIELD S, VLAHOV D, KASLOW R, SAAH A, RINALDO C, DETELS R, HEMOPHILIA GROWTH AND DEVELOPMENT STUDY, MULTICENTER AIDS COHORT STUDY, SAN FRANCISCO CITY COHORT, ALIVE STUDY, O'BRIEN SJ: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273:1856-1862, 1996.
10. DENG H, UNUTMAZ D, KEWALRAMANI VN, LITTMAN DR: Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388:296-300, 1997.
11. DORANZ BJ, GROVIT-FERBAS K, SHARRON MP, MAO S, GOETZ MB, DAAR ES, DOMS RW, O'BRIEN WA: A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J.Exp.Med. 186:1395-1400, 1997.
12. DORANZ BJ, RUCKER J, YI Y, SMYTH RJ, SAMSON M, PELPER SC, PARMENTIER M, COLLMAN RG, DOMS RW: A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR2b as fusion cofactors. Cell 85:1149-1158, 1996.
13. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673, 1996.
14. ENDRES MJ, CLAPHAM PR, MARSH M, AHUJA M, TURNER JD, MCKNIGHT A, THOMAS JF, STOEBENAU-HAGGARTY B, CHOE S, VANCE PJ, WELLS TNC, POWER CA, SUTTERWALA SS, DOMS RW, LANDAU NR, HOXIE JA: CD4-independent infection by HIV-2 is mediated by Fusin/CXCR4. Cell 87:745-756, 1996.
15. + lymphocytes. J Immunol 140:2237-2242, 1988.
16. +T cells is independent of transcription and translation. J Immunol 155:2902-2910, 1995.
17. LIAO F, ALKHATIB G, PEDEN KWC, SHARMA G, BERGER EA, FARBER JM: STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophagetropic and T cell line-tropic HIV-1. J Exp Med 185: 2015-2023, 1997.
18. LIPES MA, NAPOLITANO M, JEANG KT, CHANG NT, LEONARD WJ: Identification, cloning, and characterization of an immune activation gene. Proc Natl Acad Sci USA 85:9704-9708, 1988.
19. LIU R, PAXTON WA, CHOE S, CERADINI D, MARTIN SR, HORUK R, MACDONALD ME, STUHLMANN H, KOUP RA, LANDAU NR: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-377, 1996.
20. LODI PJ, GARRETT DS, KUSZEWSKI J, TSANG MLS, WEATHER-BEE JA, LEONARD WJ, GRONENBORN AM, CLORE GM: High-resolution solution strucuture of the β-chemokine hMIP-1β by multidimensional NMR. Science 263:1762-1767, 1994.
21. MACKEWICZ CE, BARKER E, LEVY JA: Role of β-chemokines in suppressing HIV replication. Science 274: 1393-1394, 1996.
22. MICHAEL NL, CHAG G, LOUIE LG, MASCOLA JR, DONDERO D, BIRX DL, SHEPPARD HW: The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med 3:338-340, 1997.
23. MURAKAMI T, NAKAJIMA T, KOYANAGI Y, TACHIBANA K, FIJTI N, TAMAMURA H, YOSHIDA N, WAKI M, MATSUMOTO A, YOSHIE O, KISHIMOTO T, YAMAMOTO N, NAGASAWA T: A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J Exp Med 186:1389-1393, 1997.
24. OBERLIN E, AMARA A, BACHELERIE F, BESSIA C, VIRELIZIER JL, ARENZANA-SEISDEDOS F, SCHWARTZ O, HEARD JM, CLARK-LEWIS I, LEGLER DF, LOETSCHER M, BAGGIOLINI M, MOSER B: The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382: 833-836, 1996.
25. ORAVECZ T, PALL M, NORCROSS MA: β-chemokine inhibition of monocytotropic HIV-1 infection: Interference with a postbinding fusion step. J Immunol 157: 1329-1332, 1996.
26. PAL R, GARZINO-DEMO A, MARKHAM PD, BURNS J, BROWN M, GALLO RC, DEVICO AL: Inhibition of HIV-1 infection by the β-chemokine MDC. Science 278:695-698, 1997.
27. SCARLATTI G, TRESOLDI E, BJORNDAL A, FREDRKSSON R, COLOGNESI C, DENG HK, MALNATI MS, PLEBANI A, SICCARDI AG, LITTMAN DR, FENYO EM, LUSSO P: In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat Med 3:1259-1265, 1997.
28. SCHALL TJ, JONGSTRA J, DYER BJ, JORGENSEN J, CLAYBERGER C, DAVIS MM, KRENSKY AM: A human T cell-specific molecule is a member of a new gene family. J Immunol 141:1018-1025, 1988.
29. SCHMIDTMAYEROVA H, SHERRY B, BUKRINSKY M: Chemokines and HIV replication. Nature 382:767, 1996.
30. SCHOLS D, STRUYF S, VAN DAMME J, ESTE JA, HENSON G, DECLERQ E: Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med 186:1383-1388, 1997.
31. SIMMONS G, CLAPHAM PR, PICARD L, OFFORD RE, ROSEN- KILDE MM, SCHWARTZ TW, BUSER R, WELLS TNC, PROUD-FOOT AEI: Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 276:276-279, 1997.
32. SMITH MW, DEAN M, CARRINGTON M, WINKLER C, HUTTLEY GA, LOMB DA, GOEDERT JJ, O'BRIEN TR, JACOBSON LP, KASLOW R, BUCHBINDER SP, VITTINGHOFF E, VLAHOV D, HOOTS K, HILGARTNER MW, HEMOPHILIA GROWTH AND DEVELOPMENT STUDY, MULTICENTER AIDS COHORT STUDY, MULTICENTER HEMOPHILIA COHORT STUDY, SAN FRANCISCO CITY COHORT, ALIVE STUDY, O'BRIEN SJ: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277:959-965, 1997.
33. TAUB DD, ORTALDO JR, TURCOVSKI-CORRALES SM, KEY ML, LONGO DL, MURPHY WJ: β-chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J Leukoc Biol 59:81-89, 1996.
34. VILLLNGER F, BRAR SS, MAYNE A, CHIKKALA N, ANSARI AA: Comparative sequence analysis of cytokine genes from human and nonhuman primates. J Immunol 155:3946-3954, 1995.
35. + T-lymphocytes supresses HIV replication. Immunology 66:628-630, 1989.
36. WELLS TNC, POWER CA, LUSTI-NARASIMHAN M, HOOGEWERF AJ, COOKE RM, CHUNG C, PEITSCH MC, PROUDFOOT AEI: Selectivity and antagonism of chemokine receptors. J Leukoc Biol 59:53-60, 1996.
37. ZACK JA, ARRIGO SJ, WEITSMAN SR, Go AS, HAISLIP A, CHEN ISY: HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile latent viral structure. Cell 61:213-222, 1990.
38. ZIPFEL PF, BALKE J, IRVING SG, KELLY K, SIEBENLIST U: Mitogenic activation of human T cells induces two closely related genes which share structural similarities with a new family of secreted factors. J Immunol 142:1582-1590, 1989.